Research-use-only labelling: what it means and what it does not

Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that.

A labelling question, and I would like the answer to be about what the words mean rather than about what people do.

"Research use only" appears on the vial and on the paperwork. Research-use-only material is not approved for human use in any jurisdiction I am aware of, and I am asking about the classification itself: what it obliges the seller to do, what it obliges the buyer to do, and what it says about the material.

I would rather have the narrow, accurate answer than the broad, comfortable one.

Answering the research-use-only labelling question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first measurement was taken.

That is a fair summary of where the discussion has got to.

If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.

Worth separating research-use-only labelling as a question about the compound from research-use-only labelling as a question about the documentation. They get answered by different people and only one of them is answerable here.

Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported.

Anyone who has looked at this more carefully, please correct the record.

The confident answers on research-use-only labelling and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.

Post #6 put the caveat in the right place and I want to underline it.

Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only compounds, which are not approved for any human use.

A label change is a regulatory event with a date and a document. Citing the document is what makes a claim about labelling checkable.

That is the version I use. It may not be the version that is correct.

Adding the boring version of research-use-only labelling, because the interesting version keeps getting posted and the boring one is usually right.

Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.

An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence.

The rule of thumb is fine; the edge cases are where it earns its keep.

Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The label does not establish whether the molecule is safe, efficacious, or toxic.

I would treat the number as indicative rather than as a measurement.

Everything in post #9 holds. The case it does not cover is the one I have.

The version of research-use-only labelling that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those conditions are where the interesting cases live.

Two people in this thread mean different things by research-use-only labelling and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing to define it.